Botanical species · safety record

Artemisia pallens

The EFSA Compendium of Botanicals holds 7 constituent measurements for Artemisia pallens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Artemisia pallens DC.

7Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Furan derivatives	Unspecified	Essential oil	—	GC-MS	Resolve DOI
Germacranolide	Aerial part of plants	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Sesquiterpene lactones type eudesmanolide	Aerial part of plants	Solvent extraction	—	Chromatographic tests	Resolve DOI
Artemisinin	Unspecified	Solvent extraction	0.103 Percent	LC-MS	No resolvable identifier
Santonin	Unspecified	Solvent extraction	≤ 40.71 Milligram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Santonin	Unspecified	Solvent extraction	≥ 1.94 Milligram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Saponins	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Kumar, A.P., Kumud, U. Pharmacognostic and phytochemical investigation of aerial parts of Artemisia pallens Wall ex.Dc. Pharmacognosy journal, 2010, vol. 2, no. 9, p. 285-288.
Ruikar, Anjali D., Jadhav, Ravindra B., Phalgune, Usha D., Rojatkar, Supada R., Puranik, Vedavati G., Deshpande, Nirmala R. Phytochemical Investigation of Artemisia pallens. Helvetica chimica acta, 2011, vol. 94, no. 1, p. 73-77. DOI
Ruikar, A., Jadhav, R., Tambe, A., Misar, A., Mujumdar, A., Puranik, V., Deshpande, N. Quantification of santonin from Artemisia pallens wall by HPTLC. International journal of pharma and bio sciences, 2010, vol. 1, no. 1.
Rojatkar, SR., Pawar, SS., Pujar, PP., Sawaikar, DD., Gurunath, S., Sathe, VT., Nagasampagi, BA. A germacranolide from Artemisia pallens. Phytochemistry, 1996, vol. 41, no. 4, p. 1105-1106. DOI
Suresh, J., Mruthunjaya, K., Paramakrishnan, N., Naganandhini, M. N. Determination of Artemisinin in Artemisia abrotanum and Artemisia pallens by LC/MS method. International journal of current pharmaceutical research, 2011, vol. 3, no. 1, p. 49-52.
MISRA, LN., CHANDRA, A., THAKUR, RS. FRAGRANT COMPONENTS OF OIL FROM ARTEMISIA-PALLENS. Phytochemistry, 1991, vol. 30, no. 2, p. 549-552. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature